Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis
Published inThe Lancet Global Health, vol. 5, no. 4, p. e439-e447
Publication date2017
Abstract
Keywords
- Antiprotozoal Agents/economics
- Chagas Disease/diagnosis/economics/ethnology
- Cost-Benefit Analysis
- Emigrants and Immigrants/statistics & numerical data
- Europe/epidemiology
- Female
- Humans
- Latin America/ethnology
- Male
- Mass Screening/economics/statistics & numerical data
- Primary Health Care/economics/organization & administration
Citation (ISO format)
REQUENA-MÉNDEZ, Ana et al. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. In: The Lancet Global Health, 2017, vol. 5, n° 4, p. e439–e447. doi: 10.1016/S2214-109X(17)30073-6
Main files (1)
Article (Published version)
Identifiers
- PID : unige:102442
- DOI : 10.1016/S2214-109X(17)30073-6
- PMID : 28256340
Journal ISSN2214-109X